Cures vs. Profits: Successes in Translational Research
"The public has a right to know that the research conducted on biomedical procedures and drugs used to treat aliments has been conducted with the highest code of ethics possible, and that less effective treatments are not being brought forward simply because they are more profitable." — Dr James Lyons-Weiler
Have you ever heard that doctors and pharmaceutical companies don't want cures, but that they only want treatments? Dr Lyons-Weiler explores that question in fine detail in his information-packed book, Cures vs Profits, exploring many examples of successes in biomedical translational success, as well as numerous examples of betrayals of the public trust.
Every day, millions of people trust their health and well-being to an increasingly corporatized and globalized health care system. How and when can we know that the treatment options we are provided with represent the best possible, and not only the most profitable, treatments and procedures available? With both deep historical and up-to-date insights on each topic presented, Dr Lyons-Weiler analyses and examines both the successes and problems with modern health care. From the significance of breast cancer receptor research for individualized treatments in other cancers to ADHD overdiagnosis and vaccines, the book represents an honest appraisal of the best and the worst in current biomedical research.
Readers will come away from this book with excellent illustrations of best practices in biomedical research, as well as clear-cut examples of what the author calls "Shamwizardry".
Cures vs Profits retails for US$28 / £18 (paperback) and US$58 / £38 (hardback) at major bookstores. To know more about the book visit http://www.worldscientific.com/worldscibooks/10.1142/9846
About the Author
Dr Lyons-Weiler is an author and research scientist from Western Pennsylvania, USA. This is his second book. His first book, Ebola: An Evolving Story provides an in-depth analysis of the interplay between faith, belief, fear, dogma, science, reason, and policy during the world's first Ebola pandemic.
About World Scientific Publishing Co.
World Scientific Publishing is a leading independent publisher of books and journals for the scholarly, research, professional and educational communities. The company publishes about 600 books annually and about 130 journals in various fields. World Scientific collaborates with prestigious organizations like the Nobel Foundation, US National Academies Press, as well as its subsidiary, the Imperial College Press, amongst others, to bring high quality academic and professional content to researchers and academics worldwide. To find out more about World Scientific, please visit http://www.worldscientific.com.
For more information, contact Amanda Yun at [email protected]